hrp0086p2-p516 | Fat Metabolism and Obesity P2 | ESPE2016

4G Polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1), PAI-1 Plasma Levels, and Lipid Profiles in Overweight/Obese Children and Adolescents

Karabouta Zacharoula , Makedou Areti , Papandreou Dimitrios , Argiriou Anagnostis , Xanthopoulou Helen , Rousso Israel , Athanassiadou-Piperopoulou Fani

Background: Studies have shown that PAI-1 4G polymorphism is related to increased plasma PAI-1 levels, obesity, dyslipidaemia and cardiovascular disease (CVD) in adults. Few studies have explored that relationship in overweight/obese (Ow/Ob) children/adolescents.Objective and hypotheses: We investigated the relation between plasma PAI-1 levels, PAI-1 4g polymorphisms and lipid profiles in Ow/Ob children/ adolescents compared with healthy normal ...